Ashland Inc. — Fourth Quarter and Full-Year Fiscal 2026 Earnings Summary

Ashland Inc. reported fourth-quarter fiscal 2026 sales of $498 million, a four percent increase from the prior year, driven by volume growth in Life Sciences and Personal Care. The company recorded a net loss of $16 million for the quarter, while Adjusted EBITDA rose two percent to $121 million. For the full fiscal year 2026, sales reached $1.863 billion, and the company generated $232 million in Ongoing Free Cash Flow. Ashland has issued a fiscal 2027 outlook projecting sales between $1.905 billion and $1.975 billion and Adjusted EBITDA between $405 million and $435 million.